Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group

Published:2013-07-30 Issue:20 Volume:119 Page:3718-3726
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Wang Larry L.¹,Suganuma Rie¹,Ikegaki Naohiko²,Tang Xao²,Naranjo Arlene³,McGrady Patrick³,London Wendy B.⁴,Hogarty Michael D.⁵,Gastier-Foster Julie M.⁶,Look A. Thomas⁷,Park Julie R.⁸,Maris John M.⁵,Cohn Susan L.⁹,Seeger Robert C.¹⁰,Shimada Hiroyuki¹

Affiliation:

1. Department of Pathology and Laboratory Medicine; Children's Hospital Los Angeles and University of Southern California Keck School of Medicine; Los Angeles California

2. Department of Anatomy and Cell Biology; College of Medicine; University of Illinois at Chicago; Chicago Illinois

3. Department of Biostatistics; Children's Oncology Group Statistics and Data Center; University of Florida; Gainesville Florida

4. Division of Hematology/Oncology; and Children's Oncology Group Statistics and Data Center; Boston Children's Hospital and Dana-Farber Cancer Institute; Harvard Medical School; Boston Massachusetts

5. Division of Oncology; Children's Hospital of Philadelphia; University of Pennsylvania School of Medicine; Philadelphia Pennsylvania

6. Department of Pathology and Laboratory Medicine; Nationwide Children's Hospital; Ohio University College of Medicine; Columbus Ohio

7. Department of Pediatric Oncology; Dana-Farber Cancer Institute; Harvard Medical School; Boston Massachusetts

8. Department of Pediatrics; Seattle Children's Hospital; University of Washington School of Medicine and Fred Hutchinson Cancer Research Center; Seattle Washington

9. Department of Pediatrics; Division of Hematology/Oncology; University of Chicago; Chicago Illinois

10. Division of Hematology/Oncology; Children's Hospital Los Angeles and University of Southern California Keck School of Medicine; Los Angeles California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28251/fullpdf

Reference33 articles.

1. Prognostic factors in neuroblastoma;Evans;Cancer.,1987

2. Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage;Brodeur;Science.,1984

3. Terminology and morphologic criteria of neuroblastic tumors: Recommendation by the International Neuroblastoma Pathology Committee;Shimada;Cancer.,1999

4. The International Neuroblastoma Pathology Classification (the Shimada System);Shimada;Cancer.,1999

5. Successful treatment of stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study;Matthay;J Clin Oncol.,1998

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ONC201 Exerts Oncogenic Effects Beyond its Mitochondria-Disturbing Role in Neuroblastoma Subsets;2024-07-19

2. Composite paraganglioma-ganglioneuroma with atypical catecholamine profile and phenylethanolamine N-methyltransferase expression: a case report and literature review;Endocrine Journal;2024

3. Advanced Pathology Classification Toward Precision Stratification of Neuroblastic Tumors;Pediatric Oncology;2024

4. Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets;Aging;2023-11-27

5. Neurorosettes: a novel computational modelling framework to investigate the Homer-Wright rosette formation in neuroblastoma;Computational Particle Mechanics;2023-08-17